Treatment of ithy, red, dry and cracked skin condition (Eczema) by of Unani drug
Phase 2
- Conditions
- Health Condition 1: null- Nar Farsi (Eczema)
- Registration Number
- CTRI/2017/12/010957
- Lead Sponsor
- Central Research Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of any sex in the age group of 18 to 65 years
2. Patients having the following symptoms:
3. Erythema
4. Scaling
5. Lichenification
6. Excoriation
Hyperpigmentation
Burnig Sensation
Itching
Exclusion Criteria
1. Patients aged below 18 years and above 65 years
2. Patients on concomitant therapy
3. Co-morbid patient
4. Patients suffering from: Diabetes mellitus, Hypertension
5. Pregnant and Lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the efficacy of Marham-e-Safeda Kafoori in the management of Nar Farsi Talluqi (Contact Eczema) <br/ ><br>To evaluate safety of Marham-e-Safeda Kafoori in the management of Nar Farsi Talluqi (Contact Eczema)Timepoint: at baseline, 7th, 14th, 21st, 28th, 35th and 42th day <br/ ><br>
- Secondary Outcome Measures
Name Time Method Assessment of safety of the study drugTimepoint: at baseline, 7th, 14th, 21st, 28th, 35th and 42th day <br/ ><br>